DEUTSCHE BANK AG\ - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,239,415
+23.5%
254,671
+36.7%
0.00%
+100.0%
Q2 2023$2,622,203
-5.9%
186,236
+3.3%
0.00%
-50.0%
Q1 2023$2,785,203
+682.1%
180,272
+729.7%
0.00%
Q4 2022$356,122
-5.5%
21,728
+6.5%
0.00%
Q3 2022$377,000
-1.0%
20,404
-29.6%
0.00%
Q2 2022$381,000
-57.5%
28,963
-70.0%
0.00%
Q1 2022$896,000
+158.2%
96,628
+172.5%
0.00%
Q4 2021$347,000
-93.2%
35,456
-76.3%
0.00%
-100.0%
Q3 2021$5,089,000
-8.1%
149,773
-1.0%
0.00%
-33.3%
Q2 2021$5,536,000
-31.1%
151,220
-15.7%
0.00%
-25.0%
Q1 2021$8,040,000
-22.3%
179,314
-1.1%
0.00%
-33.3%
Q4 2020$10,349,000
-18.8%
181,333
-27.0%
0.01%
-33.3%
Q3 2020$12,748,000
+19.9%
248,500
+39.6%
0.01%
+12.5%
Q2 2020$10,634,000
+89.4%
178,071
+30.5%
0.01%
+60.0%
Q1 2020$5,616,000
-45.1%
136,404
-17.0%
0.01%
-28.6%
Q4 2019$10,232,000
+29.8%
164,431
-29.2%
0.01%
+40.0%
Q3 2019$7,884,000
+254.7%
232,378
+135.6%
0.01%
+400.0%
Q2 2019$2,223,000
-1.2%
98,629
+1.6%
0.00%0.0%
Q1 2019$2,251,000
+10.6%
97,098
+0.1%
0.00%0.0%
Q4 2018$2,036,000
-79.6%
97,011
-62.4%
0.00%
-66.7%
Q3 2018$9,987,000
+11.4%
257,982
+13.2%
0.00%0.0%
Q2 2018$8,967,000
+4129.7%
227,897
+2046.7%
0.00%
Q1 2018$212,000
-48.3%
10,616
-41.4%
0.00%
Q4 2017$410,00018,1010.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders